243 related articles for article (PubMed ID: 9863301)
1. [Treatment of multiple sclerosis--2. Application of a new immunological basic research is close].
Svenningsson A; Andersson M; Olsson T
Lakartidningen; 1998 Dec; 95(49):5631-5. PubMed ID: 9863301
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic immunomodulation in neurology: from hope to reality. Exemplified by multiple sclerosis].
Schluep M; Regli F
Praxis (Bern 1994); 1995 Sep; 84(38):1021-4. PubMed ID: 7481299
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of immunology to the treatment of multiple sclerosis].
Pérez-Miranda J; Parrilla-Ramírez JL
Rev Neurol; 1998 Jul; 27(155):117-21. PubMed ID: 9674043
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of mitoxantrone in multiple sclerosis--what is known?
Neuhaus O; Kieseier BC; Hartung HP
J Neurol Sci; 2004 Aug; 223(1):25-7. PubMed ID: 15261556
[TBL] [Abstract][Full Text] [Related]
5. The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy.
Kieseier BC; Archelos JJ; Storch M; Gold R; Hartung HP
Wien Klin Wochenschr; 1999 Sep; 111(17):728-37. PubMed ID: 10526397
[TBL] [Abstract][Full Text] [Related]
6. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
Rodríguez-Rodríguez Y; Suárez-Luis I
Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of action of glatiramer acetate treatment in multiple sclerosis.
Racke MK; Lovett-Racke AE; Karandikar NJ
Neurology; 2010 Jan; 74 Suppl 1():S25-30. PubMed ID: 20038760
[TBL] [Abstract][Full Text] [Related]
8. Immunopathogenesis and immunotherapy of multiple sclerosis.
Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
[TBL] [Abstract][Full Text] [Related]
9. [Immunomodulatory therapy in multiple sclerosis].
Csépány T; Bereczki D
Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapeutic approaches in multiple sclerosis.
Adorini L
J Neurol Sci; 2004 Aug; 223(1):13-24. PubMed ID: 15261555
[TBL] [Abstract][Full Text] [Related]
11. Disease-modifying drugs for the early treatment of multiple sclerosis.
Flachenecker P
Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
[TBL] [Abstract][Full Text] [Related]
12. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
Tourbah A; Fontaine B; Lyon-Caen O
Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies in MS: mechanisms of action.
Bielekova B; Becker BL
Neurology; 2010 Jan; 74 Suppl 1():S31-40. PubMed ID: 20038761
[TBL] [Abstract][Full Text] [Related]
14. [Multiple sclerosis: epidemiology, molecular pathology and therapy].
Steck AJ; Schaeren-Wiemers N
Schweiz Med Wochenschr; 1999 Nov; 129(46):1764-8. PubMed ID: 10603650
[TBL] [Abstract][Full Text] [Related]
15. [Recent progress in treatment for multiple sclerosis].
Kira J
Rinsho Shinkeigaku; 2000 Dec; 40(12):1261-3. PubMed ID: 11464473
[TBL] [Abstract][Full Text] [Related]
16. [New approaches in research of therapy of multiple sclerosis].
Hemmer B; Cepok S; Nessler S; Sommer N
Med Klin (Munich); 2001 Sep; 96 Suppl 1():23-8. PubMed ID: 11603112
[TBL] [Abstract][Full Text] [Related]
17. [Abnormalities in the immune system of MS patients and possibilities of immunological treatment].
Salonen R; Ilonen J
Duodecim; 1992; 108(1):82-92. PubMed ID: 1365988
[No Abstract] [Full Text] [Related]
18. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
Fontoura P; Garren H; Steinman L
Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
[TBL] [Abstract][Full Text] [Related]
19. [Immunological mechanisms involved in the pathogenesis of multiple sclerosis].
Correale J
Rev Neurol; 2000 Sep 1-15; 31(5):471-6. PubMed ID: 11027101
[TBL] [Abstract][Full Text] [Related]
20. Animal models for multiple sclerosis.
Owens T
Adv Neurol; 2006; 98():77-89. PubMed ID: 16400828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
